NewAmsterdam Pharma Co. NV (NAMS)
22.11
-0.16
(-0.72%)
USD |
NASDAQ |
Oct 07, 16:00
22.11
0.00 (0.00%)
After-Hours: 16:24
NewAmsterdam Pharma Price to Book Value : 4.120 for Oct. 7, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 06, 2026 | 4.150 |
| October 05, 2026 | 4.248 |
| October 02, 2026 | 4.323 |
| October 01, 2026 | 4.502 |
| September 30, 2026 | 4.532 |
| September 29, 2026 | 4.436 |
| September 28, 2026 | 4.394 |
| September 25, 2026 | 4.207 |
| September 24, 2026 | 4.237 |
| September 23, 2026 | 4.226 |
| September 22, 2026 | 4.345 |
| September 21, 2026 | 4.207 |
| September 18, 2026 | 4.190 |
| September 17, 2026 | 4.086 |
| September 16, 2026 | 3.946 |
| September 15, 2026 | 3.943 |
| September 14, 2026 | 4.166 |
| September 11, 2026 | 4.248 |
| September 10, 2026 | 4.073 |
| September 09, 2026 | 4.246 |
| September 08, 2026 | 4.776 |
| September 04, 2026 | 4.733 |
| September 03, 2026 | 4.817 |
| September 02, 2026 | 4.768 |
| September 01, 2026 | 4.643 |
| Date | Value |
|---|---|
| August 31, 2026 | 4.722 |
| August 28, 2026 | 4.826 |
| August 27, 2026 | 4.992 |
| August 26, 2026 | 5.105 |
| August 25, 2026 | 5.094 |
| August 24, 2026 | 5.003 |
| August 21, 2026 | 5.193 |
| August 20, 2026 | 5.176 |
| August 19, 2026 | 5.316 |
| August 18, 2026 | 5.077 |
| August 17, 2026 | 5.012 |
| August 14, 2026 | 5.027 |
| August 13, 2026 | 4.969 |
| August 12, 2026 | 5.186 |
| August 11, 2026 | 5.146 |
| August 10, 2026 | 5.214 |
| August 07, 2026 | 5.210 |
| August 06, 2026 | 5.156 |
| August 05, 2026 | 5.109 |
| August 04, 2026 | 5.133 |
| August 03, 2026 | 5.122 |
| July 31, 2026 | 5.178 |
| July 30, 2026 | 5.303 |
| July 29, 2026 | 5.200 |
| July 28, 2026 | 5.214 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ProQR Therapeutics NV | 2.524 |
| Pharming Group NV | 2.671 |
| argenx SE | -- |
| Ionis Pharmaceuticals, Inc. | 16.64 |
| Arcutis Biotherapeutics, Inc. | 13.76 |
Price to Book Value Related Metrics
| PS Ratio | 371.41 |
| PEG Ratio | -0.2896 |
| Price | 22.11 |
| Earnings Yield | -9.85% |
| Market Cap | 2.601B |
| PEGY Ratio | -0.2896 |